PRAMEF5

Across TCGA patient cohorts, PRAMEF5 mutation is significantly associated with the immune_cell of many other genes, with 1 significant associations in total. COAD shows the largest number of these associations.

The most reproducible PRAMEF5-associated genes across cancer lineages are CD4+ naive T-cells. Each is linked with PRAMEF5 in more than 1 cancer types. Because this analysis shows association rather than direction, both PRAMEF5-to-partner and partner-to-PRAMEF5 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, CD4+ naive T-cells grouped by PRAMEF5-low versus PRAMEF5-high in COAD.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (PRAMEF5→partner) and Y-score (partner→PRAMEF5) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
COAD	CD4+ naive T-cells →	+0.021	+5.142	<.001	.041	3	1

Each partner links to its Q-omics profile. Showing the 1 strongest of 1 associations by consensus.

CD4+ naive T-cells by PRAMEF5 expression — COAD

Explore this box plot interactively →